Pfizer Says Study Links Celebrex, Heart Risk
Pharmaceutical company Pfizer announces that its popular painkiller Celebrex may increase the risk of cardiovascular problems. New study results indicate more than double the risk of major heart problems, but another study failed to corroborate the finding. NPR's Richard Knox reports.
Related NPR Stories
Pfizer Stock Takes Hit on Celebrex News Dec. 17, 2004
Comments
Discussions for this story are now closed. Please see the Community FAQ for more information.